Integrity Implants d/b/a Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive spine surgery, and CHP Merger announced that the companies have mutually agreed to terminate their business combination agreement. Both parties cited market conditions as trhe reason for calling off the deal.
CHP said it would liquidate and return shareholders’ money. The SPAC less than a month ago announced it had secured working capital of up to $1.5 million from its sponsor.
Announced in November, the deal was valued at $482 million. Read more.
